<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR267">
 <label>267.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Neelapu</surname>
    <given-names>SS</given-names>
   </name>
   <name>
    <surname>Locke</surname>
    <given-names>FL</given-names>
   </name>
   <name>
    <surname>Bartlett</surname>
    <given-names>NL</given-names>
   </name>
   <name>
    <surname>Lekakis</surname>
    <given-names>LJ</given-names>
   </name>
   <name>
    <surname>Miklos</surname>
    <given-names>DB</given-names>
   </name>
   <name>
    <surname>Jacobson</surname>
    <given-names>CA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma</article-title>
  <source>N Engl J Med</source>
  <year>2017</year>
  <volume>377</volume>
  <fpage>2531</fpage>
  <lpage>2544</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1707447</pub-id>
  <?supplied-pmid 29226797?>
  <pub-id pub-id-type="pmid">29226797</pub-id>
 </element-citation>
</ref>
